Aging and heart failure :
Aging and heart failure : mechanisms and management /
edited by Bodh I. Jugdutt.
- xxii, 475 páginas : 84 ilustraciones, 50 ilustraciones en color.
Springer eBooks
Changing demographics of the aging population with heart failure and implications for therapy -- Biology of aging and implications for heart failure therapy and prevention -- Hypertension and prevention of diastolic heart failure in the aging population -- Aging and optimal therapy of systolic heart failure in the elderly -- Atrial fibrillation and heart failure in the aging population -- Optimizing therapy of heart failure in the aging population with monitoring in clinics -- Cardiac alterations in aging, hypertension and diastolic heart failure -- Polypharmacy and adverse drug reactions in the aging population with heart failure -- Aging-related changes in vascular biology and implications for heart failure therapy in the aging population -- Biomarkers and optimal management of heart failure in the aging population -- Benefits of Exercise in the elderly -- The RAAS in heart failure: an update on clinical trials and opportunities for therapy -- Aging and diastolic dysfunction – the interplay of inflammation and extracellular matrix regulation -- Reperfusion and vasodilator therapy in elderly patients with STEMI and heart failure. Improving outcomes -- Erythropoietin therapy for heart failure -- Role of resistin in heart failure in the elderly -- Role of coronary artery calcium in cardiovascular risk stratification and management in the aging population -- Aging-and remodeling of the RAS and RAAS and related pathways. Implications for heart failure therapy -- Aging and right ventricular failure from pulmonary hypertension: Effect of right ventricular and pulmonary artery remodeling -- Biomarkers of cardiovascular aging -- Changes in the heart that accompany advancing age: Humans to molecules -- Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy -- Aging-related changes in telomeres and telomerases and implications for heart failure therapy -- Aging associated alterations in myocardial inflammation and fibrosis: pathophysiological perspectives and clinical implications -- Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction -- Calcium handling defects and changes in cardiac function in the aging heart -- Integrins: Implications for aging in heart failure therapy -- Adipokines as novel biomarkers in aging and heart failure -- Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy -- Aging-related changes in mitochondrial function and implication for heart failure therapy -- Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart -- SMP-30 and aging-related cardiac remodeling and heart failure.
9781493902682
RC681-688.2
Springer eBooks
Changing demographics of the aging population with heart failure and implications for therapy -- Biology of aging and implications for heart failure therapy and prevention -- Hypertension and prevention of diastolic heart failure in the aging population -- Aging and optimal therapy of systolic heart failure in the elderly -- Atrial fibrillation and heart failure in the aging population -- Optimizing therapy of heart failure in the aging population with monitoring in clinics -- Cardiac alterations in aging, hypertension and diastolic heart failure -- Polypharmacy and adverse drug reactions in the aging population with heart failure -- Aging-related changes in vascular biology and implications for heart failure therapy in the aging population -- Biomarkers and optimal management of heart failure in the aging population -- Benefits of Exercise in the elderly -- The RAAS in heart failure: an update on clinical trials and opportunities for therapy -- Aging and diastolic dysfunction – the interplay of inflammation and extracellular matrix regulation -- Reperfusion and vasodilator therapy in elderly patients with STEMI and heart failure. Improving outcomes -- Erythropoietin therapy for heart failure -- Role of resistin in heart failure in the elderly -- Role of coronary artery calcium in cardiovascular risk stratification and management in the aging population -- Aging-and remodeling of the RAS and RAAS and related pathways. Implications for heart failure therapy -- Aging and right ventricular failure from pulmonary hypertension: Effect of right ventricular and pulmonary artery remodeling -- Biomarkers of cardiovascular aging -- Changes in the heart that accompany advancing age: Humans to molecules -- Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy -- Aging-related changes in telomeres and telomerases and implications for heart failure therapy -- Aging associated alterations in myocardial inflammation and fibrosis: pathophysiological perspectives and clinical implications -- Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction -- Calcium handling defects and changes in cardiac function in the aging heart -- Integrins: Implications for aging in heart failure therapy -- Adipokines as novel biomarkers in aging and heart failure -- Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy -- Aging-related changes in mitochondrial function and implication for heart failure therapy -- Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart -- SMP-30 and aging-related cardiac remodeling and heart failure.
9781493902682
RC681-688.2